Business Description
Zhejiang Chemsyn Pharm Co Ltd
ISIN : CNE100006CY8
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.53 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.08 | |||||
Interest Coverage | 11.06 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 30.64 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.3 | |||||
3-Year EBITDA Growth Rate | 44.2 | |||||
3-Year EPS without NRI Growth Rate | 49.6 | |||||
3-Year FCF Growth Rate | 41.9 | |||||
3-Year Book Growth Rate | 38 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.02 | |||||
9-Day RSI | 57.68 | |||||
14-Day RSI | 48.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.98 | |||||
Quick Ratio | 5.9 | |||||
Cash Ratio | 4.22 | |||||
Days Inventory | 91.43 | |||||
Days Sales Outstanding | 44.87 | |||||
Days Payable | 37.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.1 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.37 | |||||
Operating Margin % | 46.4 | |||||
Net Margin % | 41.38 | |||||
FCF Margin % | 20.41 | |||||
ROE % | 36.39 | |||||
ROA % | 33.26 | |||||
ROIC % | 62.8 | |||||
ROC (Joel Greenblatt) % | 107.26 | |||||
ROCE % | 44.47 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.56 | |||||
PE Ratio without NRI | 9.51 | |||||
Price-to-Owner-Earnings | 17.07 | |||||
PEG Ratio | 0.17 | |||||
PS Ratio | 3.94 | |||||
PB Ratio | 4.59 | |||||
Price-to-Tangible-Book | 5.03 | |||||
Price-to-Free-Cash-Flow | 19.34 | |||||
Price-to-Operating-Cash-Flow | 12 | |||||
EV-to-EBIT | 8.73 | |||||
EV-to-EBITDA | 8.01 | |||||
EV-to-Revenue | 4.43 | |||||
EV-to-FCF | 21.7 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.32 | |||||
Price-to-Graham-Number | 1.46 | |||||
Price-to-Net-Current-Asset-Value | 8.22 | |||||
Price-to-Net-Cash | 15.28 | |||||
Earnings Yield (Greenblatt) % | 11.45 | |||||
FCF Yield % | 3.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zhejiang Chemsyn Pharm Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 232.248 | ||
EPS (TTM) (Â¥) | 1.6 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 48.42 | ||
14-Day ATR (Â¥) | 0.388744 | ||
20-Day SMA (Â¥) | 15.03 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (Â¥) | 14.2 - 19.91 | ||
Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang Chemsyn Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang Chemsyn Pharm Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang Chemsyn Pharm Co Ltd Frequently Asked Questions
What is Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)'s stock price today?
When is next earnings date of Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656)?
Does Zhejiang Chemsyn Pharm Co Ltd(BJSE:870656) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |